Cargando…

Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge

BACKGROUND: Acute coronary syndrome includes life-threatening clinical conditions ranging from unstable angina to non-Q-wave myocardial infarction and Q-wave myocardial infarction that are a major cause of emergency medical care and hospitalization in the United States. The American College of Cardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Helen Y., Cooke, Catherine E., Robertson, Teisha A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438254/ https://www.ncbi.nlm.nih.gov/pubmed/18439049 http://dx.doi.org/10.18553/jmcp.2008.14.3.271

Ejemplares similares

Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq
por: Nassr, Ola A., et al.
Publicado: (2019)

Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: a multicentre study
por: Tra, J., et al.
Publicado: (2015)

Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
por: Berger, Jeffrey S.
Publicado: (2018)

Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study
por: Chow, Clara K, et al.
Publicado: (2019)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study
por: Zhao, Mei, et al.
Publicado: (2022)

Present and future of secondary prevention after an acute coronary syndrome
por: Keller, Pierre-Frederic, et al.
Publicado: (2011)

Use of medicines recommended for secondary prevention of acute coronary syndrome
por: Gaedke, Mari Ângela, et al.
Publicado: (2015)

Adherence to Prescribing Guideline-Directed Medical Therapy at Hospital Discharge in Subjects With Acute Coronary Syndrome, and the Relationship With Mortality
por: Alkofide, Hadeel, et al.
Publicado: (2022)

Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan
por: Ahmed, Kannan O, et al.
Publicado: (2022)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
por: Husted, Steen
Publicado: (2015)

Religious practices and long-term survival after hospital discharge for an acute coronary syndrome
por: Abu, Hawa O., et al.
Publicado: (2019)

Predicting Statin Adherence Following Hospital Discharge for Acute Coronary Syndromes: What’s the Score?
por: Barlow, Thomas R., et al.
Publicado: (2023)

Suboptimal Utilization of Secondary Drug Prevention in Acute Coronary Syndrome: Measurement Issues and Managed Care Opportunities
por: Quilliam, Brian J.
Publicado: (2008)

Bleeding After Hospital Discharge Following Acute Coronary Syndrome: Incidence, Types, Timing, and Predictors
por: Ismail, Nafiu, et al.
Publicado: (2019)

Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden
por: Begum, Najida, et al.
Publicado: (2015)

Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome
por: Fitchett, David H., et al.
Publicado: (2020)

Effect and safety of antithrombotic therapies for secondary prevention after acute coronary syndrome: a network meta-analysis
por: Mo, Fanrui, et al.
Publicado: (2018)

Religious practices and changes in health-related quality of life after hospital discharge for an acute coronary syndrome
por: Abu, Hawa O., et al.
Publicado: (2019)

Quality of Life of Patients After an Acute Coronary Event: Hospital Discharge
por: Dias, Cristiane Maria Carvalho Costa, et al.
Publicado: (2014)

Evaluation of proper prescribing of cardiac medications at hospital discharge for patients with acute coronary syndromes (ACS) in two Lebanese hospitals
por: Sheikh-Taha, Marwan, et al.
Publicado: (2014)

Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention
por: Kilic, Ismail Dogu, et al.
Publicado: (2020)

Variability of discharge medical therapy for secondary prevention among patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) in the United States
por: Smilowitz, Nathaniel R., et al.
Publicado: (2021)

Relationship Between β‐Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Li, Chenze, et al.
Publicado: (2016)

Changing the Landscape of Secondary Prevention After Acute Coronary Syndrome: Morphology, Physiology, or Both?
por: Otake, Hiromasa
Publicado: (2022)

Higher baseline lipid levels amplify the benefit of secondary prevention therapy with statins in Chinese patients with acute coronary syndrome
por: Zhu, Ling, et al.
Publicado: (2020)

Acute Coronary Syndrome Secondary to Aortocaval Fistula
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2019)

Are there gender differences in acute management and secondary prevention of acute coronary syndromes in Barbados? A cohort study
por: Sobers, Natasha, et al.
Publicado: (2019)

Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea
por: Byeon, Hee Ja, et al.
Publicado: (2016)

Implantable Cardioverter‐Defibrillator Therapy in Patients With Ventricular Fibrillation out of Hospital Cardiac Arrest Secondary to Acute Coronary Syndrome
por: Madhavan, Malini, et al.
Publicado: (2015)

Medication Literacy in a Cohort of Chinese Patients Discharged with Acute Coronary Syndrome
por: Zhong, Zhuqing, et al.
Publicado: (2016)

Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay
por: Laurencet, Marie-Eva, et al.
Publicado: (2016)

Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
por: Nicholls, Justine, et al.
Publicado: (2017)

Betaine and Secondary Events in an Acute Coronary Syndrome Cohort
por: Lever, Michael, et al.
Publicado: (2012)

Dual antiplatelet therapy for secondary prevention of coronary artery disease
por: Degrauwe, Sophie, et al.
Publicado: (2017)

Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
por: Chen, Yan, et al.
Publicado: (2020)

Discharge of Acute Coronary Syndrome Patients on Sub-Optimal Dual Anti-Platelet Therapy: A Single Center Experience
por: Booker, Jeffrey, et al.
Publicado: (2023)

A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial
por: Kanagaratnam, Prapa, et al.
Publicado: (2023)

Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
por: Zhu, Ling, et al.
Publicado: (2020)

Predictors allowing early discharge after interventional treatment of acute coronary syndrome patients
por: Bauer, Dávid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_002lr6iaca1nm7lblkp12eg46l